Qure.ai
40% of their time is spent on manually collecting data, which the tool would assist in reducing.
Also, Mediwhale raised $12 million for its United States expansion.
Also, Qure.ai has obtained breakthrough device designation for its tuberculosis AI.
Also, Qure.ai has received its 13th FDA approval for its AI-based medical imaging software.
They will deploy AI to help reduce delays and gaps in stroke care management.
Qure.ai's qXR software will enable Mylab's upcoming x-ray device to quickly detect TB.
Also, AIRS Medical has proved the capability of its AI MRI reconstruction tool to denoise and improve the quality of 3D MR images.
Also: Digital mental health company Brightside Health scores $50 million, and Qure.ai brings in $40 million for its imaging algorithms.
Also, HCA Healthcare UK opens £26M specialist oncology unit at UCLH.
Also: Truepill launches a COVID-19 test coverage platform for insurers, and 23andMe extends its partnership with GSK.